» Articles » PMID: 28684345

Alterations in Nociception and Morphine Antinociception in Mice Fed a High-fat Diet

Overview
Journal Brain Res Bull
Specialty Neurology
Date 2017 Jul 8
PMID 28684345
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, more than 78.6 million adults in the United States are obese. A majority of the patient population receiving treatment for pain symptoms is derived from this subpopulation. Environmental factors, including the increased availability of food high in fat and sugar, contribute to the continued rise in the rates of obesity. The focus of this study was to investigate whether long-term exposure to a high-fat, energy-dense diet enhances baseline thermal and inflammatory nociception while reducing sensitivity to morphine-induced antinociception. Antinociceptive and hypothermic responses to morphine were determined in male and female C57BL/6N mice fed either a "western-style" diet high in fat and sucrose (HED) or a standard low-fat chow diet for 15 weeks. Antinociception was assessed using both the hot plate and tail flick tests of acute thermal pain and the formalin test of inflammatory pain. Acute administration of morphine dose-dependently increased antinociception in the hot plate and tail flick assays for mice of both sexes fed chow and HED. However, female mice displayed lower antinociceptive response to morphine compared to males in the tail-flick test. Hypothermic responses to acute morphine were also assessed in mice fed chow or HED. Male and female mice fed chow, and female mice fed HED displayed similar hypothermic responses to morphine. However, males fed HED did not exhibit morphine-induced hypothermia. Tolerance to the antinociceptive and hypothermic effects of morphine was assessed after ten days of repeated daily administration (10mg/kg morphine). Male mice fed chow or HED developed tolerance to morphine in the hot plate test. However, females fed HED did not. In the tail flick assay, only mice fed HED developed tolerance to morphine. All groups showed tolerance to morphine-induced hypothermia. In the formalin test, we found that both male and female mice fed HED had reduced sensitivity to the antinociceptive effects of morphine (6mg/kg). Collectively, these data suggest that sensitivity and tolerance to the antinociceptive effects of morphine may be dependent on diet and sex in the hot plate and tail flick thermal pain models, and that the acute antinociceptive effects of morphine in the formalin inflammatory pain model may also be dependent on these two factors. In addition, diet and sex can influence morphine-induced hypothermia. Exposure to an HED may lead to changes in neuronal signaling pathways that alter nociceptive responses to noxious stimuli in a sex-specific manner. Thus, dietary modifications might be a useful way to impact pain therapy.

Citing Articles

The Effects of Eating a Traditional High Fat/High Carbohydrate or a Ketogenic Diet on Sensitivity of Female Rats to Morphine.

Beltran N, Parra A, Serrano A, Castillo J, Castro I, Elsey M J Pharmacol Exp Ther. 2024; 391(1):30-38.

PMID: 39060162 PMC: 11415821. DOI: 10.1124/jpet.124.002188.


Decursinol-mediated antinociception and anti-allodynia in acute and neuropathic pain models in male mice: Tolerance and receptor profiling.

Crawford L, Kim S, Karelia D, Sepulveda D, Morgan D, Lu J Front Pharmacol. 2022; 13:968976.

PMID: 36249788 PMC: 9558739. DOI: 10.3389/fphar.2022.968976.


c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner.

Henderson-Redmond A, Nealon C, Davis B, Yuill M, Sepulveda D, Blanton H Neuropharmacology. 2019; 164:107847.

PMID: 31758947 PMC: 8190707. DOI: 10.1016/j.neuropharm.2019.107847.


Binge-Like Exposure to Ethanol Enhances Morphine's Anti-nociception in B6 Mice.

Chang S, Huang W, Han H, Sariyer I Front Psychiatry. 2019; 9:756.

PMID: 30723430 PMC: 6349749. DOI: 10.3389/fpsyt.2018.00756.


Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice.

Nealon C, Henderson-Redmond A, Hale D, Morgan D Neuropharmacology. 2019; 148:151-159.

PMID: 30629988 PMC: 6535342. DOI: 10.1016/j.neuropharm.2018.12.026.